{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:48:42Z","timestamp":1760100522139},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/ppo.0b013e3182624664","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T21:05:47Z","timestamp":1343423147000},"page":"372-380","source":"Crossref","is-referenced-by-count":5,"title":["Genetic Testing by Cancer Site"],"prefix":"10.1097","volume":"18","author":[{"given":"Michele","family":"Gabree","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10897-008-9187-7","article-title":"Cowden syndrome: a critical review of the clinical literature.","volume":"18","author":"Pilarski","year":"2009","journal-title":"J Genet Couns"},{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/GIM.0b013e3181ac9aea","article-title":"PTEN hamartoma tumor syndrome: an overview.","volume":"11","author":"Hobert","year":"2009","journal-title":"Genet Med"},{"key":"R3-14-20210203","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","article-title":". Birt-Hogg-Dube syndrome: diagnosis and management.","volume":"10","author":"Menko","year":"2009","journal-title":"Lancet Oncol"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.ejhg.5201923","article-title":". Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1.","volume":"16","author":"Kruger","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"R5-14-20210203","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1684\/ejd.2009.0749","article-title":"Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.","volume":"19","author":"Badeloe","year":"2009","journal-title":"Eur J Dermatol"},{"key":"R6-14-20210203","first-page":"764","article-title":"Multiple endocrine neoplasia type 2: an overview.","volume":"755-","author":"Moline","year":"13","journal-title":"Genet Med"},{"key":"R7-14-20210203","first-page":"93","article-title":"The neurofibromatoses.","volume":"82-","author":"Ferner","year":"10","journal-title":"Pract Neurol"},{"key":"R8-14-20210203","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":". Neurofibromatosis type 1 revisited.","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"R9-14-20210203","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":". Neurofibromatosis type 2.","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"key":"R11-14-20210203","first-page":"20","article-title":"Tuberous sclerosis complex: tumors and tumorigenesis.","volume":"13-","author":"Borkowska","year":"50","journal-title":"Int J Dermatol"},{"key":"R12-14-20210203","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1470-2045(08)70126-8","article-title":"Lessons from the skincutaneous features of familial cancer.","volume":"9","author":"Winship","year":"2008","journal-title":"Lancet Oncol"},{"key":"R15-14-20210203","doi-asserted-by":"crossref","first-page":"677e1","DOI":"10.1016\/j.jaad.2009.03.016","article-title":". Selection criteria for genetic assessment of patients with familial melanoma.","volume":"61","author":"Leachman","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R17-14-20210203","first-page":"1310","article-title":"The Breast Cancer Linkage Consortium.","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R18-14-20210203","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1002\/cncr.23963","article-title":". Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.","volume":"113","author":"Dores","year":"2008","journal-title":"Cancer"},{"key":"R20-14-20210203","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jmg.2004.022731","article-title":"Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.","volume":"41","author":"Hemminki","year":"2004","journal-title":"J Med Genet"},{"key":"R21-14-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00008390-200202000-00008","article-title":". Rarity of CDK4 germline mutations in familial melanoma.","volume":"12","author":"Goldstein","year":"2002","journal-title":"Melanoma Res"},{"key":"R22-14-20210203","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/sj.onc.1206445","article-title":"Genetics of melanoma predisposition.","volume":"22","author":"Hayward","year":"2003","journal-title":"Oncogene"},{"key":"R23-14-20210203","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":". High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"key":"R24-14-20210203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00008390-199408000-00001","article-title":". Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype.","volume":"4","author":"Newton Bishop","year":"1994","journal-title":"Melanoma Res"},{"key":"R25-14-20210203","first-page":"452","article-title":"Genetics: what advice for patients who present with a family history of melanoma Semin Oncol.","volume":"34","author":"Newton Bishop","year":"2007","journal-title":""},{"key":"R26-14-20210203","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1470-2045(06)71010-5","article-title":"Management of familial melanoma.","volume":"8","author":"Bishop","year":"2007","journal-title":"Lancet Oncol"},{"key":"R27-14-20210203","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":". Geographical variation in the penetrance of CDKN2A mutations for melanoma.","volume":"94","author":"Bishop","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R28-14-20210203","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jnci\/dji312","article-title":". Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.","volume":"97","author":"Begg","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R30-14-20210203","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/ijc.23396","article-title":". MC1R variants, melanoma and red hair color phenotype: a meta-analysis.","volume":"122","author":"Raimondi","year":"2008","journal-title":"Int J Cancer"},{"key":"R31-14-20210203","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1158\/1078-0432.CCR-08-0403","article-title":". Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.","volume":"14","author":"de Snoo","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R32-14-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/hmg\/10.1.55","article-title":". A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.","volume":"10","author":"Randerson-Moor","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R33-14-20210203","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archderm.136.9.1118","article-title":". Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.","volume":"136","author":"Tsao","year":"2000","journal-title":"Arch Dermatol"},{"key":"R34-14-20210203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.cmr.0000131014.79262.bf","article-title":". Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma.","volume":"14","author":"Berg","year":"2004","journal-title":"Melanoma Res"},{"key":"R35-14-20210203","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2008.12.034","article-title":". Patterns of photoprotection following CDKN2Ap16 genetic test reporting and counseling.","volume":"60","author":"Aspinwall","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R36-14-20210203","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1158\/1055-9965.EPI-08-0010","article-title":". CDKN2Ap16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.","volume":"17","author":"Aspinwall","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R38-14-20210203","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00000658-200212000-00005","article-title":". CDKN2A germline mutations in familial pancreatic cancer.","volume":"236","author":"Bartsch","year":"2002","journal-title":"Ann Surg"},{"key":"R40-14-20210203","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-3-32","article-title":"Nevoid basal cell carcinoma syndrome (Gorlin syndrome).","volume":"3","author":"Lo Muzio","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"R43-14-20210203","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1365-4632.2007.03391.x","article-title":"Correlations between the sonic hedgehog pathway and basal cell carcinoma.","volume":"46","author":"Lupi","year":"2007","journal-title":"Int J Dermatol"},{"key":"R44-14-20210203","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1741-4520.2008.00212.x","article-title":". Further delineation of 9q22 deletion syndrome associated with basal cell nevus (Gorlin) syndrome: report of two cases and review of the literature.","volume":"49","author":"Yamamoto","year":"2009","journal-title":"Congenit Anom (Kyoto)"},{"key":"R45-14-20210203","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/ajmg.a.32944","article-title":". Identification of a SUFU germline mutation in a family with Gorlin syndrome.","volume":"149A","author":"Pastorino","year":"2009","journal-title":"Am J Med Genet A"},{"key":"R46-14-20210203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jmg.2007.055343","article-title":". A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family.","volume":"45","author":"Fan","year":"2008","journal-title":"J Med Genet"},{"key":"R48-14-20210203","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.GIM.0000145045.17711.1C","article-title":". Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or Gorlin) syndrome.","volume":"6","author":"Kimonis","year":"2004","journal-title":"Genet Med"},{"key":"R49-14-20210203","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.11537","article-title":"Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.","volume":"98","author":"Amlashi","year":"2003","journal-title":"Cancer"},{"key":"R50-14-20210203","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1186\/1757-1626-2-9399","article-title":". Odontogenic keratocysts in nevoid basal cell carcinoma syndrome: a case report.","volume":"2","author":"Mohtasham","year":"2009","journal-title":"Cases J"},{"key":"R52-14-20210203","first-page":"88","article-title":". Cardiac fibroma as an inherited manifestation of nevoid basal-cell carcinoma syndrome.","volume":"33","author":"Bossert","year":"2006","journal-title":"Tex Heart Inst J"},{"key":"R54-14-20210203","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/jhg.2009.55","article-title":". Germline PTCH1 mutations in Japanese basal cell nevus syndrome patients.","volume":"54","author":"Takahashi","year":"2009","journal-title":"J Hum Genet"},{"key":"R57-14-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1.","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R58-14-20210203","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.nrl.0000195830.22432.a5","article-title":"Neurofibromatosis types 1 and 2.","volume":"12","author":"Yohay","year":"2006","journal-title":"Neurologist"},{"key":"R59-14-20210203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10897-007-9101-8","article-title":". Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.","volume":"16","author":"Radtke","year":"2007","journal-title":"J Genet Couns"},{"key":"R61-14-20210203","first-page":"116","article-title":"Neoplasms associated with germline and somatic NF1 gene mutations.","volume":"101-","author":"Patil","year":"17","journal-title":"Oncologist"},{"key":"R64-14-20210203","first-page":"543","article-title":"Therapeutics for childhood neurofibromatosis type 1 and type 2.","volume":"529-","author":"Ardern-Holmes","year":"13","journal-title":"Curr Treat Options Neurol"},{"key":"R65-14-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1022020000598","article-title":". Genetic counseling, reproductive behavior and future reproductive intentions of people with neurofibromatosis type 1 (NF1).","volume":"7","author":"Ponder","year":"1998","journal-title":"J Genet Couns"},{"key":"R66-14-20210203","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review.","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"R67-14-20210203","first-page":"347","article-title":"Meningiomas and neurofibromatosis.","volume":"341-","author":"Goutagny","year":"99","journal-title":"J Neurooncol"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00130404-201207000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:56:37Z","timestamp":1618037797000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130404-201207000-00014"}},"subtitle":["Skin"],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e3182624664","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}